期刊文献+

精神分裂症服用氯氮平能降低其甲状腺素水平的对照分析 被引量:3

It was decreased for thyroxine in schizophrenics taking clozapine
下载PDF
导出
摘要 目的 探索氯氮平治疗是否影响T3 、T4和TSH水平。方法 对 17例精神分裂症患者 ,给予氯氮平治疗第 4天和第 4周末分别测定T3 、T4和TSH水平。结果 治疗第 4周末的T3 (3 30 9± 0 6 89)、T4(9 4 4 9± 1 94 1)水平比第 4天的T3 (3 915± 0 85 0 )、T4(11 178± 2 180 )水平明显降低 (P均 <0 0 5 )。 Objective To explore whether clozapine can influened T 3,T 4 and TSH level.Method It was estimated for T 3,T 4 and TSH in 17 schizophrenics taking clozapine at posttreatment 4th day and 28th day,respectively.Results It was significantly decreased for posttreatment 28th day T 3(3.309±0.689) and T 4(9.449±1.941) than posttreatment 4th day T 3(3.915±0.850) and T 4(11.178±2 180)( P <0 05).Conclusion It was significantly decreased for thyroxine in schizophrenics taking clozapine.
出处 《四川精神卫生》 2003年第2期68-70,共3页 Sichuan Mental Health
  • 相关文献

参考文献6

  • 1喻东山.减分率公式的修正[J].临床精神医学杂志,1995,5(1):12-12.
  • 2喻东山,张心保.神经递质与精神药理[J].国外医学(精神病学分册),1998,25(4):204-207. 被引量:16
  • 3中华医学会精神科分会.中国精神障碍分类与诊断标准(第三版)[M].济南:山东科学技术出版社,2001.91-95.
  • 4Parry AK. Ormqrod LP. Hamlin GW, et al. Recurrent sinus arrest in association with neuroleptic malignant syndrome. Br J Psychiatry,1994,164(4) :689-691.
  • 5Baraban JM, Worley PF Snyder SH. Second messenger systems and psychoactive drug action: focus on the phesphoinosetide system and lithium. Am J Psychiatry, 1989,146(10) :1251.
  • 6Hendrlch V, Alishuler L, Whybrow P. Psychoneuroendocrinology of mood disorders: The hypothalamic pituitary, Thyroid axis psychiat.Clin North Am, 1998,21 ( 3 ) :277 - 292.

共引文献102

同被引文献22

  • 1司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘.10省市抗精神病药使用现况的调查[J].中华精神科杂志,2004,37(3):152-155. 被引量:95
  • 2宋兵福,陈志敏,周慧静,王文玲.抗精神病药物与血糖调节异常的短期监测[J].神经疾病与精神卫生,2005,5(5):377-378. 被引量:2
  • 3张文亮.抗精神病药物对糖、脂代谢的影响及对策[J].中国药物滥用防治杂志,2006,12(1):31-33. 被引量:5
  • 4刘晓芹,蒋德珍,董小惠.氯氮平对血清甲状腺素和血糖、血脂水平的影响[J].神经疾病与精神卫生,2006,6(2):115-116. 被引量:2
  • 5[2]Othman SS,Abdul Kadir k Hassan J,ET AL.High prevalence of thyroid functiontest abnormalities in chronic schizophrenia[J].Aust NZ J Psychiatry.1995,29(1):157~159
  • 6[4]Hsieh MT,Wu L, ET AL. Inhibitory effects of(+/-) -tetrahydropalmatine on thyrotropin-stimulating hormone concentration in hyperthyroid rats[J].J Pharm Pharmacol. 1996,48(9):959~961
  • 7MelkerssonK,Dahl ML.Adverse metabolic effects associated with atypical antipsychotics:literature review and clinical implications[J].Drugs,2004,64(7):701-723.
  • 8Sim K,ChongSA,Chan YH,et al.Thyroid dysfunction in chronic schizophrenia within a state psychiatric hospital[J].Ann Acad Med Singapore,2002,31(5):641-644.
  • 9Newcomer JW.Abnormalities of glucose metabolism associated with atypical antipsychotic drugs[J].J Clin Psychiatry,2004,18:36-46.
  • 10KroezeWK,HufeisenSJ,PopadakBA,et al.H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychticd drugs[J].Neuropsychopharmacology,2003,28:519-526.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部